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Copenhagen, DenmarkChromosome 17q12-21 remains the most highly replicated and
significant asthma locus. Genotypes in the core region defined
by the first genome-wide association study correlate with
expression of 2 genes, ORM1-like 3 (ORMDL3) and gasdermin
B (GSDMB), making these prime candidate asthma genes,
although recent studies have implicated gasdermin A (GSDMA)
distal to and post-GPI attachment to proteins 3 (PGAP3)
proximal to the core region as independent loci. We review
10 years of studies on the 17q12-21 locus and suggest that
genotype-specific risks for asthma at the proximal and distal loci
are not specific to early-onset asthma and mediated by PGAP3,
ORMDL3, and/or GSDMA expression. We propose that the
weak and inconsistent associations of 17q single nucleotide
polymorphisms with asthma in African Americans is due to the
high frequency of some 17q alleles, the breakdown of linkage
disequilibrium on African-derived chromosomes, and possibly
different early-life asthma endotypes in these children. Finally,
the inconsistent association between asthma and gene expression
levels in blood or lung cells from older children and adults
suggests that genotype effects may mediate asthma risk or
protection during critical developmental windows and/or in
response to relevant exposures in early life. Thus studies of
young children and ethnically diverse populations are required
to fully understand the relationship between genotype and
asthma phenotype and the gene regulatory architecture at this
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The first genome-wide association study (GWAS) of asthmawas
reported 10 years ago by Moffatt et al,1 who made the seminal dis-
covery of a novel asthma locus on chromosome 17q21, which was
defined by a large 206.5-kb region. This locus has since been
extended to include single nucleotide polymorphisms (SNPs)
both proximal and distal* to the core locus initially defined byMof-
fatt et al and is more accurately referred to as the 17q12-21 asthma
locus, although in this review we will refer to it simply as 17q.
Subsequent GWASs and meta-analyses of GWASs have
highlighted 17q as the most replicated and most significant
asthma locus.2-10 Genotypes at SNPs in the core region defined by
Moffat et al1 have been shown to correlate with the expression
of 2 genes, ORM1-like 3 (ORMDL3) and gasdermin B
(GSDMB),1,11-23 making these the prime candidate asthma genes
at this locus. More recent studies have implicated gasdermin
A (GSDMA)3,24 distal to and Post-GPI attachment to proteins 3
(PGAP3) (previously named PERLD1)2,20,25 proximal to the
core region as potentially independent asthma loci (Fig 1, A and
B).2 Follow-up studies of 17q comprised a significant proportion
of asthma-related genetic research over the past decade; however,
many questions remain. Here we overview our current
understanding of this important locus, focusing on clinical
correlations and the genomic, transcriptomic, and epigenomic
studies of this region. Throughout, we highlight 17 SNPs that cap-
ture the signature genetic findings (Fig 2).1-3,5,6,10,14,20,21,23-35 We
refer readers to Das et al36 for an excellent review of functional
studies of genes at the 17q locus.PHENOTYPES AND ENDOTYPES ASSOCIATED
WITH THE 17Q12-21 LOCUS
Despite the fact that the 17q locus shows the strongest
associations in large GWASs and meta-analyses, the odds ratios
(ORs) of these associations are modest. For example, in the
Transnational Genetics of Asthma Consortium (TAGC) meta-
analysis,2 which included 75 independent GWASs comprising
ethnically diverse populations totaling 23,948 cases and 118,538
control subjects, the lead SNP at the 17q locus had a P value of
2.2 3 10230 (Fig 1, A) but an OR of only 1.16 (95% CI,
1.13-1.19). This likely reflects the extensive clinical heterogeneity*The terms proximal and distal are used in this review to refer to locations relative to the
centromere.
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750 STEIN ET ALAbbreviations usedASMC: Airway smooth muscle cellBEC: Bronchial epithelial cellCEU: Utah residents with Northern and Western European
ancestry from the CEPH collectionCOPSAC: Copenhagen Prospective Studies on Asthma in Childhood
birth cohortCTCF: CCCTC-binding factoreQTL: Expression quantitative trait locusERBB2: Erb-b2 receptor tyrosine kinase 2ETS: Environmental tobacco smokeGPI: GlycosylphosphatidylinositolGSDMA: Gasdermin AGSDMB: Gasdermin BGWAS: Genome-wide association studyIKZF3: IKAROS family zinc finger 3LCL: Lymphoblastoid cell lineLD: Linkage disequilibriumOR: Odds ratioORMDL3: ORM1-like 3PBL: Peripheral blood leukocytePCA: Principal components analysisPGAP3: Post-GPI attachment to proteins 3SNP: Single nucleotide polymorphismTRM: Tissue-resident memoryYRI: Yoruba in Ibadan, NigeriaZPBP2: Zona pellucida binding protein 2of asthma, with variation in age of onset, co-occurrence with
allergic sensitization, and manifestation of wheezing illnesses in
early life. Moreover, asthma risk is affected significantly by
environmental exposures in the first few years of life, including
environmental tobacco smoke (ETS), older siblings, furred pets,
and large farm animals, which also vary among GWAS subjects.
In fact, studies of more clinically homogeneous cases or
accounting for relevant exposures have yielded increased ORs
for asthma-associated loci, including 17q.37Age of onset and early-life exposures
It is clear that the core 17q locus is associated with early-onset
asthma,2,6,14,27,28,38,39 which was first reported by Bouzigon
et al,28 who showed that associations with 17q genotypes were
restricted to children with onset of asthma symptoms before the
age of 4 years (Fig 3, A).28 Furthermore, the association with
early-onset asthma was present only in children exposed to ETS
in early life. Associations with early age of onset were replicated
in subsequent studies that further extended this observation to
Asian subjects,14 more severe symptoms in early childhood,14,38
bronchial hyperresponsiveness at 1 month of age,38 exacerbations
and hospitalization before age 6 years,6 older siblings,33
rhinovirus-associated wheezing illnesses in the first 3 years of
life,12 and wheezing in the first year of life (Fig 3, B).12,33,40
The observation that 17q-associated asthma risk is modified by
early-life exposure to ETS28 was replicated in 2 Dutch birth
cohorts,41 Croatian children,29 and United Kingdom adults24
but not in the Danish National Birth Cohort42 or the European
GABRIEL consortium.43
Surprisingly, the same alleles that are associated with asthma
risk in the above studies were associated with protection from
wheezing among children exposed to animal barns in the first yearof life (Fig 3, C).33 This protection was dose dependent: exposure
of more than 2 hours a week to animal barns was associated with a
greater than 80% reduction in wheezing among children with
‘‘high-risk’’ genotypes (rs8076131 AG or GG).
In this same study therewas no interaction between genotype and
dog ownership on wheezing,33 although significant interactions
were reported between the 17q genotype and furred pets on
wheezing in the first 18 months of life in the Danish National Birth
Cohort study42 and on asthma at school age in Croatian children29
and Danish children in the Copenhagen Prospective Studies on
Asthma in Childhood birth cohort (COPSAC)2000 study.
44 In these
studies genotypes at 17q SNPs were associated with protection
among children with a cat or dog. In the COPSAC2000 study cat
(but not dog) allergen levels were associated with asthma among
children with the rs7216389 TT genotype.Associations of the 17q12-21 locus with other
phenotypes and diseases
Genotypes at the 17q locus show inconsistent associations with
asthma-associated phenotypes. SNPs at this locus were not
associated with allergic sensitization11,12,14,38,40,45 or atopic
dermatitis38,46,47 in GWASs or in 17q-focused studies. Although
GWASs of total serum IgE levels did not report associations
with 17q SNPs,3,48-53 a 17q-focused study reported an association
with IgE in ethnic Chinese subjects from Singapore.11 Two
17q-focused studies reported associations with allergic
rhinitis,54,55 but a GWAS56 and other 17q-focused studies11,33,38
did not. Neither GWASs57-61 nor 3 17q-focused studies24,38,45
reported associations with lung function, whereas one
17q-focused study did.29 One GWAS of fraction of exhaled nitric
oxide reported associations between 17q SNPs,62 whereas
another did not show evidence of association,63 and one
17q-focused study reported associations with blood
eosinophilia,11 although one GWAS did not.64
Interestingly, 17q SNPs have been associated with other
diseases in GWASs, all of which are autoimmune in cause: Crohn
disease,65 ulcerative colitis,66 inflammatory bowel disease,67 type
I diabetes,68,69 rheumatoid arthritis,70 and primary biliary
cirrhosis.71,72 Although the same SNPs are associated with both
asthma and autoimmune disease, the risk alleles associated with
autoimmune disease are opposite of those associated with asthma
risk, as previously noted.23,73,74 These findings suggest that genes
at the core locus affect immune development broadly.23
Moreover, the overlapping associations of asthma and
autoimmune disease with SNPs at the core region, but not at the
proximal or distal regions, suggest that the latter 2 regions may
confer lung specificity to asthma, whereas SNPs at the core region
might be more central to early-life immune responses to
asthma-promoting or asthma-protective exposures.FINE MAPPING AND ETHNIC-SPECIFIC
ASSOCIATIONS AT THE 17Q LOCUS
Fine mapping at the 17q locus has been challenging because of
the extensive linkage disequilibrium (LD) in populations of
European, Latino, and Asian ancestry (Fig 1, D) and the weak
and inconsistent evidence for association between asthma and 17q
SNPs in populations of African ancestry.5,35,75-77 Coregulation of
genes at this locus and different patterns of gene regulation in blood
and lung cells impose additional layers of complexity.
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LD is very strong between SNPs at the 17q locus, with an
extended haplotype spanning the entire core region in
populations of European, Latino, and East Asian ancestry
(Fig 1, D). This feature makes it virtually impossible to
distinguish the effects of specific SNPs with any confidence.
In fact, the evidence for association between SNPs across
the core region and asthma is strong and consistent in
Europeans,2,3,5 Latinos,10,35 and ethnic Chinese from
Singapore11 and Hong Kong.78-80 Associations are less
consistent in smaller studies of Han Chinese from China81-83
and of Korean14,84,85 and Japanese53,86 subjects.
In contrast, LD extends over much shorter distances in
African Americans (Fig 1, D) and Africans (see Fig E1
and Table E1 in this article’s Online Repository at
www.jacionline.org), except for a region in GSDMB defined
by 3 SNPs that shows near-perfect LD in all populations; these
were the most significant SNPs in GWASs of asthma in
Europeans,3,6 ethnically diverse US populations5 and in a
17q-focused study in Han Chinese.82 The 3 SNPs consist of
a common missense variant that is predicted to be ‘‘possibly
damaging’’ by PolyPhen (rs2305480; c.892C>T,
p.P298S),26,87 an intronic variant that affects alternatively
spliced transcript abundances (rs11078928; c.662T>C),31 and
an intronic variant of unknown function (rs11078927). The
rs11078928-T allele is associated with higher expression of
GSDMB caused by aberrant splicing, and the very high
frequency of this allele in African Americans (approximately
0.82) could contribute to the high prevalence of asthma among
these subjects.
In the EVE meta-analysis the most significant association in
African Americans was with rs11078927, making this the most
significant association in the combined sample.Althoughofmodest
significance inAfricanAmericans (P5.0019), the estimated effect
size for rs11078927was similar to those reported for the other EVE
populations. This is likely due to the high frequency of the 3
GSDMB SNPs in African Americans (0.82), which reduces power
to detect associations (Fig 1, C).
The breakdown of LD in the core region in African Americans
should facilitate fine mapping of the 17q locus if the true causal
variants are genotyped or tagged by the SNPs typed in those
studies. The inconsistency between studies raises the possibility
that the 17q-associated riskmight involvemultiple variants across
the extended haplotype that are not in LD and possibly not tagged
by the GWAS SNPs on African-derived chromosomes.
Ethnicity-specific rare variants at the 17q locus could also
influence asthma risk, although a study of rare coding variants
in 2308 African American cases and control subjects found no
significant associations at 17q genes.26 However, the array used
included only 57% (8/14) of the missense, nonsense, or splicing
variants discovered in 17q genes in whole-genome sequences
from 93 of the African American asthmatic patients in this study,
raising the possibility that rare variants may have been missed.
These important questions will be addressed by the Consortium
on Asthma among African Ancestry Populations in the
Americas (CAAPA)88 in an asthma GWAS in nearly 18,000
subjects of African ancestry by using whole-genome sequences
from a subset of samples as the imputation reference panel.
Finally, it is also possible that the natural history of early-life
asthma among African American children differs from that of
children of European ancestry with respect to age of onset,virus-associated wheezing illness, or environmental exposures
that modify or interact with the 17q-associated risk. In fact, US
inner-city African American children had lower rates of virus
detection overall, fewer rhinovirus infections in particular, and
higher rates of adenovirus infection and adenovirus-associated
illness in the first year of life compared with children of European
ancestry living inMadison,Wisconsin.89 Thus the specific type of
asthma in African American children might be less influenced by
variation at the 17q locus or by different variants than are
associated with asthma in other children. It is likely that 1 or
more of these factors could be masking associations with SNPs
at the 17q locus in populations of African ancestry.Evidence for 3 independent asthma associations at
the 17q locus
Several lines of evidence suggest that SNPs in GSDMA and
PGAP3 can have effects that are independent of SNPs at the
core locus. In all populations the LD that characterizes the core
region decays in the distal region encoding GSDMA and the
proximal region encoding PGAP3 and Erb-b2 receptor tyrosine
kinase 2 (ERBB2; LD r2 <_ 0.5; Fig 1,D), and residual associations
with asthma remained at rs3894194 inGSDMA3 and rs2941504 in
PGAP314 after conditioning on SNPs at the core locus. Moreover,
because the association with asthma at both regions is reduced in a
pediatric sample (see Fig E8 in Demenais et al2), the effects of
variation at the proximal and distal loci might not be specific to
childhood-onset asthma. SNP rs2941504 in PGAP3 was also
associated with allergic asthma, but not with atopy among
nonasthmatic subjects, in ethnic Chinese adults from Singapore.25
SNP rs3894194 in GSDMA was also associated with current
asthma, FEV1, and airway hyperresponsiveness, as well as
showing interactive effects with cigarette smoking and current
asthma in a 17q-focused study of 1018 United Kingdom adults.24
Another SNP in GSDMA, rs3859192, is a strong expression
quantitative trait locus (eQTL) for GSDMA in whole lung
tissue,15,30 although it shows little LD in all populations with
the asthma-associated GSDMA SNP rs3894194.CELL-SPECIFIC EXPRESSION AND eQTL STUDIES
OF 17Q GENES
Patterns of gene expression and eQTLs in asthma-relevant
tissues (ie, immune cells and lung cells) can provide clues as to
which genes contribute to asthma pathogenesis and potentially
which SNPs are either themselves causal or tag causal variation.
Although nearly all the 17q genes are expressed ubiquitously in
asthma-relevant cell types, relative expression patterns and
associations with SNPs (ie, eQTLs) differ between these cells.Patterns of gene expression
Six of the 7 genes at the 17q locus potentially implicated in
asthma risk (PGAP3, ERBB2, IKAROS family zinc finger 3
[IKZF3], GSDMB, ORMDL3, and GSDMA; Fig 1, B, shown in
red) are expressed at detectable levels in RNA from whole
blood,30 lymphoblastoid cell lines (LCLs),23 PBMCs,90
peripheral blood leukocytes (PBLs; Stein, unpublished), lung
CD41 tissue-resident memory (TRM) cells (Schoettler,
unpublished), whole-lung tissue,30 freshly isolated bronchial
epithelial cells (BECs),20 and cultured primary airway smooth
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Location SNP bp position SNP Type Associations in published studies
PGAP3 rs2941504 17:37,830,900 Synonymous 
(c.465G>A,
p.Val104)
PGAP2 rs2517955 17:37,843,681 Intron (C>T)
ERBB2 rs2952156 17:37,876,835 Intron (G>A) Lead SNP in the TAGC GWAS2
IKZF3 rs907092 17:37,922,259 Synonymous 
(c.1314G>A; 
p.Ser438)
IKZF3 rs9303277 17: 37,976,469 Intron (T>C)
ZPBP2 rs12936231 17: 38,029,120 Intron (T>C)
Intergenic rs8069176 17: 38,057,197 (G>A)
GSDMB rs2305480 17:38,062,196 Missense 
(c.892G>A, 
p.Pro298Ser)
GSDMB rs11078927 17:38,064,405 Intron (C>T) Lead SNP in EVE GWAS5
GSDMB rs11078928 17:38,064,469 Splice variant 
(c.662T>C)
GSDMB rs2290400 17:38,066,240 Intron (T>C)
GSDMB rs7216389 17:38,069,949 Intron (T>C)
ORMDL3 rs4065275 17: 38,080,865 Intron (A>G)
ORMDL3 rs8076131 17:38,080,912 Promoter (A>G)
ORMDL3 rs12603332 17:38,082,807
GSDMA rs3894194 17: 38,121,993 Missense 
(c.536G>A, 
p.Ala18Gln)
Independent GWAS signal for asthma3, 24
GSDMA rs3859192 17: 38,128,648 Intron (C>T) eQTL for GSDMA in lung tissue
FIG 2. Seventeen SNPs in the extended 17q12-21 region that are reported to be associated with asthma,
gene expression, or epigenetic modification. Base pair position from build hg19 is shown. SNP type is
shown as ancestral > derived alleles. TAGC, Transnational Genetics of Asthma Consortium.
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STEIN ET AL 753muscle cells (ASMCs; Thompson, unpublished). By using
quantitative PCR to measure transcript levels, zona pellucida
binding protein 2 (ZPBP2) expression was also detected in
LCLs23 and cord blood mononuclear cells.32 Among immune
cell types, transcript levels of ORMDL3 and GSDMB were most
highly expressed in T and B cells,21,34 and in one study ORMDL3
was most highly expressed in eosinophils.17
ORMDL3 and GSDMB transcription increases in response to
viral infection. Expression levels of both ORMDL3 and GSDMB,
but not IKZF3, increased in PBMCs from 96 adults after exposure
to rhinovirus,90 and ORMDL3 expression levels were higher
in PBMCs from 10 children with respiratory syncytial
virus–induced bronchiolitis compared with 15 uninfected
children.91ORMDL3 expression was increased in primary human
lung fibroblasts, but not in primary human BECs or primary
human ASMCs, after exposure to polyinosinic:polycytidylicFIG 1. The 17q12-21 asthma locus. A, Regional association plot of 17q SNPs with asthma in TAGC (children
plus adults). The lead SNP, rs2952156 (purple diamond), is in ERBB2 in the proximal 17q region. All other
SNPs are colored based on their LD with the lead SNP (see inset). Modified with permission from Demenais
et al.2 B, Location of genes at the 17q locus. The 6 genes highlighted in this review are shown in blue,
orange, and green to correspond to the proximal, core, and distal regions, respectively. C, Frequencies of
asthma-associated alleles at 17 SNPs in 1000 Genomes reference panels: African Americans (American of
African Ancestry in SW USA [ASW] and African Caribbeans in Barbados [ACB]), Europeans (CEU, British
in England and Scotland [GBR], and Toscani in Italy [TSI]), Latinos (Mexican Ancestry from Los Angeles,
USA [MXL] and Puerto Ricans from Puerto Rico [PUR]), East Asians (Han Chinese in Beijing [CHB], Japanese
in Tokyo [JPT], Southern Han Chinese [CHS], Chinese Dai in Xishuangbanna [CDX], and Kinh in HoChi Minh
City [KHV]). D, LD (r2) among the 17 SNPs described in Fig 2 in African Americans (upper panel), Europeans
(lower left panel), Latinos (lower middle panel), and East Asians (lower right panel) determined by using the
same 1000 Genomes reference panels as in Fig 1, C. Asthma-associated alleles are shown for each SNP.
*Associated allele is ancestral. Data for Fig 1, C and D, are from ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/=release/20130502/.acid, a Toll-like receptor 3 ligand but not in response to LPS in any
of the cells.53 The response of these genes to important respiratory
tract viruses further supports an important role for this locus in
early-life wheezing illness and childhood-onset asthma.
As expected, relative expression of the 17q genes varies by cell
type, but the patterns of variation are revealing. In all cells
examined here (Fig 4 and see the Methods section in this article’s
Online Repository at www.jacionline.org),20 GSDMA transcripts
were expressed at levels just greater than the lower limits of
detection in most subjects, and therefore conclusions about this
gene should be tempered by this observation. Moreover, this
broader view of gene expression across the 17q locus shows
that within subjects, transcript levels of ORMDL3 were most
correlated with those of PGAP3 and not those of GSDMB in
PBLs, BECs, and ASMCs (Figs 4 and 5).20 In lung CD41 TRM
cells, ORMDL3 expression was not correlated with expression
FIG 3. SNPs in the 17q core region are associated with early-life onset and risk of or protection from
wheezing illness. A, Ordered-subset regression analysis of asthma was performed for 11 SNPs associated
with asthma in the Epidemiological Study on Genetics and Environment of Asthma sample (EGEA;
n 5 1511). The maximal difference in likelihood ratio test statistics for association between the ordered
age-specific subsets and the total sample was for an onset of asthma of 4 years or younger. SNP
rs9303277 showed the largest difference in the likelihood ratio test statistics. The EGEA included children
from 388 nuclear families with at least 1 asthmatic member living in one of 5 French cities. Modified with
permission from Bouzigon et al.28 B, Risk for asthma based on the rs7216389 genotype is confined to
children who wheezed in the first 3 years of life (Childhood Origins of Asthma [COAST], n 5 200; COPSAC,
n5 297)12 or in the first year of life (Protection against Allergy Study in Rural Environments [PASTURE] birth
cohort, n 5 696).33 Dashed horizontal lines show the overall prevalence of asthma at age 6 years in each
sample. COAST, COPSAC, and PASTURE are birth cohort studies in Madison, Wisconsin; Copenhagen,
Denmark; and rural areas of Europe, respectively. The children in COAST had at least 1 parent with asthma
or allergies, the children in COPSAC had a mother with asthma, and the children in PASTURE were
unselected with respect to asthma or allergy. Modified from Bønnelykke et al.40 C, In the PASTURE study
children with the asthma-associated allele rs8076131-A and exposed to animal barns have significantly
fewer wheezing illnesses in the first year of life. Used with permission from Loss et al.33
J ALLERGY CLIN IMMUNOL
SEPTEMBER 2018
754 STEIN ET ALof any other 17q genes, although the sample size was smallest for
these cells.Cell type–specific eQTLs
Published eQTL studies of 17q SNPs and genes are summarized
in Table I.1,11-23 To further evaluate the effects of genotype at the 17
SNPs highlighted in this review on the expression levels of the 6
candidate 17q genes, we extracted data from the Genotype-
Tissue Expression (GTEx) project for whole blood and lung tissue
(Fig 6).30 In whole blood all 17 SNPs were significant eQTLs for
ORMDL3 and GSDMB but not for any of the other 17q genes. At
each SNP, the asthma-associated allele was correlated with
increased expression of ORMDL3 and GSDMB. Thus, as in
previous studies (Table I), SNPs at the 17q core locus are strong
eQTLs for these 2 genes in peripheral blood cells from populations
of primarily non-African ancestry.
A different picture emerges in lung tissue cells. SNPs across the
region are significant eQTLs for ORMDL3, which is similar to
studies in blood but with overall smaller effects (Fig 6). However,
only the 6 most significant eQTLs for ORMDL3 are also more
modest eQTLs forGSDMB. Notably, the splice variant inGSDMB
is not an eQTL for GSDMB in lung tissue. In contrast to eQTLs in
blood, SNPs in the core and distal regions are also eQTLs for
GSDMA. Additionally, SNPs in the proximal and core regions are
strong eQTLs for PGAP3. The asthma-associated alleles at each
of these SNPs are correlated with increased expression of both
PGAP3 and ORMDL3, whereas in the distal region the asthma
risk alleles at rs3894194 and rs3859192 are correlated with lower
expression of GSDMA, as previously reported.15,92 These data
further suggest that expression of ORMDL3 and GSDMB are not
coregulated in lung cells, as they are in blood cells, as suggested
previously in studies of BECs.20
To examine eQTL patterns in a population with less LD across
this region, we extracted eQTL data for 17q SNPs from a studyof LCLs from the Nigerian HapMap population (Yoruba in
Ibadan, Nigeria [YRI]; Fig 7).5,93 In contrast to studies in whole
blood and in populations of primarily non-African ancestry, the
17q SNPs were only significant eQTLs for ORMDL3 in
African-derived LCLs, showing considerably less evidence as
eQTLs for GSDMB. Moreover, among the SNPs in the core
region, the strongest eQTL for ORMDL3 was rs12936231 in
ZPBP2 (P 5 5.35 3 10210); the strength of the associations
between other SNPs and ORMDL3 expression were correlated
with the degree of LD with rs12936231, a strong functional
candidate for the observed associations with 17q SNPs
(discussed below).21,23 Additionally, 2 SNPs in PGAP3 are
associated with ORMDL3 expression, despite little LD between
these SNPs in these regions (Fig 1, D). This possibly reflects
long-range interactions between a putative enhancer in PGAP3
and the ORMDL3 promoter in LCLs,20 further suggesting
independent effects of SNPs in the proximal region onORMDL3
expression. Although we cannot exclude the 6 less informative
SNPs in the core region from being eQTLs because of the very
low power to detect associations in this sample, these data
indicate that the effect of rs12936231 on ORMDL3 expression
levels is independent of the other 17q SNPs. Curiously,
rs12936231 was not associated with asthma in African
Americans in the EVE Consortium,5 despite having an allele
frequency near 0.50 and high statistical power to detect
association. These findings suggest that increased expression
of GSDMB or ORMDL3 in circulating immune cells might not
be causally related to asthma, as has been previously
suggested.14Gene expression differences between asthmatic
and nonasthmatic subjects
The observation that 17q SNPs are associated both with asthma
risk and expression levels of 17q genes does not consistently
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FIG 4. Relative expression of 17q genes in different tissues and cells. A, PBLs (n5 112). B, Lung CD41 TRMs
(n 5 18). C, BECs (n 5 85).20 D, ASMCs (n 5 67). Expression levels of ORMDL3 and PGAP3 were most
correlated in PBLs (ORMDL3 vs PGAP3 r 5 0.410, P 5 7.3 3 1026 cf. ORMDL3 vs GSDMB r 5 0.369,
P 5 6.2 3 1025), BECs (ORMDL3 vs PGAP3 r 5 0.693, P 5 1.9 3 10213 cf. ORMDL3 vs GSDMB r 5 0.320,
P 5 2.8 3 1023), and ASMCs (ORMDL3 vs PGAP3 r 5 0.450, P 5 1.3 3 1024 cf. ORMDL3 vs GSDMB
r 5 0.221, P 5 .07). ORMDL3 expression was not correlated with expression of any 17q genes in lung
CD41 TRMs (ORMDL3 vs PGAP3 r 5 0.077, P 5 .76 cf. ORMDL3 vs GSDMB r 5 0.400, P 5 .10). Gene
expression levels in Fig 4, A-C, are from RNA-seq; counts are shown as relative expression normalized to
all genes detected as expressed within each cell type. Gene expression in Fig 4, D, is based on microarrays;
expression levels were normalized to have amean of zero and scaled between25 and 10. Methods for PBLs,
CD41 TRMs, and ASMCs are described in the Methods section in this article’s Online Repository; methods
for BECs are reported in Nicodemus-Johnson et al.20
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STEIN ET AL 755extend to differences in 17q gene expression levels between
asthmatic and nonasthmatic subjects. For example, one small
study of Swedish asthmatic and nonasthmatic school-aged
children34 reported differences in 17q gene expression levels in
PBMCs: ORMDL3 transcript abundance was greater in 16
children with controlled asthma compared with that in 15 healthy
control subjects and 16 children with severe asthma (P 5 .002,
ANOVA); however, there were no differences between children
with severe asthma and control subjects. In the original GWAS
by Moffatt et al,1 transcript levels of ORMDL3 in LCLs werenot significantly different between 112 asthmatic and 266
nonasthmatic children. None of the 17q genes were differentially
expressed in BECs from 55 adults withmild-to-severe asthma and
26 healthy control subjects20 or in 42 adults with mild-to-
moderate asthma and healthy control subjects.94 In contrast,
ORMDL3 expression was increased in BECs from 19 adults
with stable mild asthma and 16 healthy control subjects (false
discovery rate, 8.5 3 1024).95 Although GSDMB transcripts
were not increased in BECs from asthmatic patients in any of
these studies, Das et al96 reported increased GSDMB protein
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756 STEIN ET ALusing immunohistochemistry in BECs from 14 asthmatic patients
compared with 7 healthy control subjects (P < .001), with
significantly more GSDMB1 cells among 7 patients with severe
asthma compared with control subjects (P < .01).
The inconsistent results and paucity of studies demon-
strating increased expression of 17q genes in asthmatic
patients is surprising. This could reflect insufficient power to
detect gene expression differences,1,20 a focus on cell types or
asthma endotypes that are unrelated to the 17q-associated risk,
and/or collection of samples at developmental windows or in
environments that are irrelevant to the 17q-associated asthma
risk.
CHROMATIN AND DNA METHYLATION STUDIES
AT THE 17Q LOCUS
Studies of chromatin architecture and DNA methylation
patterns in blood and lung cells have provided insight into the
specific SNPs that regulate gene expression at this locus.500
1250 1500 1750 2000 2250 2500
ORMDL3 Expression (adjusted counts)
FIG 5. Expression of ORMDL3 and PGAP3 transcripts in BECs from
85 adults. Correlation between ORMDL3 (x-axis) and PGAP3 (y-axis) in
85 subjects (r 5 0.693, P 5 1.9 3 10213, as Fig 4). Expression levels are
shown as read counts adjusted for unwanted variation, as described in
Nicodemus-Johnson et al.20Allele-specific chromatin states and DNA
methylation in immune cells
Verlaan et al23 were the first to study cis regulatory elements
associated with gene expression patterns and genotypes at
SNPs at the core 17q locus. Using LCLs from 53 European
(Utah residents with Northern and Western European ancestry
from the CEPH collection [CEU]) HapMap samples, they first
showed that the asthma-associated alleles were on an extended
haplotype that was associated with increased expression of
ORMDL3 and GSDMB. They further showed that the nonrisk
G allele at rs12936231 in ZPBP2 was depleted of nucleosomes
(a signature of regions with regulatory function) and enriched
for inactive chromatin marks and binding of CCCTC-binding
factor (CTCF), an important protein that can act as both an
insulator between regulatory domains and a mediator of
enhancer-promoter interactions.97 Therefore this study
discovered an asthma-associated SNP, rs12936231, that alters
the chromatin state of a regulatory domain and is correlated
with expression of ORMDL3 and GSDMB.
This observation was extended by Schmiedel et al,21 who
assessed the open chromatin state in 62 primary cell types at
the core 17q locus (from IKZF3 to GSDMA), as well as
allele-specific associations with enhancer activity, CTCF
binding, and gene expression in 10 immune cell types and
BECs. Overall, 17q genes were more transcriptionally active in
immune cells than in nonimmune cells, as measured by the
number of open chromatin sites assessed based on DNase
hypersensitivity (DNase-hypersensitive sites). Many of the
DNase-hypersensitive sites in T cells, B cells, and natural killer
cells overlapped asthma-associated SNPs, including the
rs12936231 SNP in ZPBP2 identified by Verlaan et al,23 as
well as SNPs in the first intron of ORMDL3, including
rs4065275. These SNPs, among others, were enriched for
H3K27ac chromatin marks of active enhancer activity in T cells;
asthma risk alleles were associated with increased enrichment of
H3K27ac. Additionally, these 2 SNPs were predicted to disrupt
CTCF-binding motifs, which were experimentally confirmed
by using chromatin immunoprecipitation sequencing: the
asthma-associated allele in ZPBP2 (rs12936231-C) disrupted a
CTCF-binding site, and the asthma-associated allele inORMDL3
(rs4065275-G) introduced a CTCF-binding site (Fig 8, A).21Finally, chromatin conformation assays (4C-seq) showed that
the ORMDL3 promoter interacts with a long-range enhancer in
IKZF3 that promotes transcription of ORMDL3 in cells that
also express IKZF3. The binding of CTCF on chromosomes
with the rs12936231-G allele in ZPBP2 blocks this interaction,
resulting in reduced transcription of ORMDL3 on haplotypes
with the rs12936231-G allele, presumably independent of
rs4065275 (Fig 8, B).98 Because IKZF3 is a transcription factor
in B cells, T cells, and selected other immune cells, the chromatin
looping and physical interaction between the IKZF3 enhancer and
the ORMDL3 promoter occurs only in immune cells. This likely
accounts for the very high expression of ORMDL3 in immune
cells compared with airway cells, where this interaction does
not occur.21
Because of the LD structure at the 17q locus, nearly
all non–African-ancestry haplotypes will carry either both
asthma-associated alleles (rs12936231-C and rs4065275-G) or
neither asthma-associated allele (rs12936231-G and rs4065275-
A), which correspond to high and low expressers of ORMDL3,
respectively (Fig 8, A). However, a recombinant haplotype with
rs12936231-G and rs4065275-G is relatively common on
African-derived chromosomes and is associated with low
expression of ORMDL3 in YRI LCLs, despite carrying the high
expressing allele rs4065275-G (Fig 8, B). As a result,
approximately 30% of African-derived chromosomes carrying
the asthma-associated rs4065275-G allele will be low expressers
of ORMDL3, whereas nearly all European- or Asian-derived
chromosomes with rs4065275-G will be high expressers of
ORMDL3. This could explain why rs4065275 is a very weak
eQTL for ORMDL3 in YRI LCLs (Fig 7).
Two studies examined allele-specific differences in DNA
methylation patterns at the core locus. Combining DNA
methylation patterns with nucleosome occupancy and in vitro
TABLE I. Published eQTL studies of 17q12-21 SNPs and genes in blood and lung cells
Study SNP
17q12-21 genes
PGAP3,
P value
ERBB2,
P value
IKZF3,
P value
ZPBP2,
P value
GSDMB,
P value
ORMDL3,
P value
GSDMA,
P value
Blood cells
Schmiedel et al21
(n 5 34),
sorted cells*
rs7216389 Naive CD41 T cells:
<.05
Treg cells: <.05
TH1 cells: <.05
B cells: <.01
NK cells: <.01
Naive CD41 T cells:
<.01
Treg cells: <.01
TH1 cells: <.001
TH2 cells: <.001
TH17 cells: <.001
B cells: <.001
NK cells: <.01
Liu et al17
(n 5 19),
sorted cells*
rs7216389 PBMCs: <_.03
PBMCs, RV inf: <_.03
CD191 B cells: .004
CD191 B cells, RV
inf: <.001
CD81 T cells,
RV inf: <_.03
CD192CD82 cells,
RV inf: <_.03
Moffat et al1
(n 5 378),
LCLs
rs7216389
rs93003277
rs2290400
rs3894194
rs3859192
3.9 3 10223
1.2 3 10222
3.9 3 10223
1.0 3 10211
3.1 3 1024
Verlaan et al23
(n 5 53), LCLs*
rs907091/rs12603332
haplotype
.0037 2.7 3 1025 3.8 3 1023
Dixon et al13
(n 5 308),
LCLs
rs2941504
rs2517955
rs907092
rs9303277
rs2305480
rs2290440
rs2716389
rs3894194
rs3859192
3 3 1024 2.6 3 1028
7.5 3 1028
2.0 3 10222
1.2 3 10222
4.9 3 10221
3.7 3 10223
4.2 3 10223
1.1 3 10211
3.0 3 1024
Andiappan et al11
(n 5 71),
whole blood
rs8076131 NS .023 .026 .0051
C¸alıs¸kan et al12
(n 5 100),
PBMCs*
rs7216389 Untreated: .11
RV inf: .16
Untreated: <.001
RV inf: <.001
Untreated: .07
RV inf: .03
Lluis et al18
(n 5 200),
CBMCs*
rs7216389 NS NS Der p 1 stim: .01 PHA stim: .0001
Der p 1 stim: .05
Halapi et al14
(n 5 473),
WBCs
rs2941504
rs907092
rs9303277
rs2305480
rs2290400
rs7216389
1.2 3 10211
5.1 3 10236
1.1 3 10241
5.5 3 10237
1.3 3 10241
2.3 3 10238
3.6 3 10221
5.1 3 10263
8.3 3 10268
9.1 3 10265
1.2 3 10260
8.8 3 10258
Sharma et al22
(n 5 200),
CD41 T cells
rs4795405 3.0 3 10210
Murphy et al19
(n 5 200),
CD41 T cells
rs2290400
rs7216389
NS
NS
NS
NS
NS
NS
3.1 3 1029
1.6 3 1028
NS
NS
(Continued)
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Study SNP
17q12-21 genes
PGAP3,
P value
ERBB2,
P value
IKZF3,
P value
ZPBP2,
P value
GSDMB,
P value
ORMDL3,
P value
GSDMA,
P value
Lung cells
Nicodemus-
Johnson et al20
(n 5 81), BECs
rs2517944
rs8076131
rs7216389
rs2305480
rs11078928
rs2941504
rs2941504
rs4065275
2.1 3 1028
8.0 3 1025
7.1 3 1025
NS
NS
NS
4.7 3 1027
2.1 3 1025
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
2.6 3 1025
3.2 3 1025
8.0 3 1025
1.1 3 1024
1.2 3 1024
1.3 3 1024
4.0 3 1025
5.5 3 1025
NS
NS
NS
NS
NS
NS
NS
NS
Hao et al15
(n 5 1111), lung
tissue
rs2290400
rs7216389
rs2305480
rs3859192
rs3894194
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
4.0 3 10215
4.2 3 10214
2.5 3 10212
3.9 3 1025
1.6 3 1027
NS
1.3 3 1026
2.1 3 1025
NS
NS
NS
8.8 3 10225
7.4 3 10232
3.6 3 10151
2.8 3 10273
Li et al16, n 5 107
for BECs and
n 5 94 for BAL
fluid
rs8067378
rs2305480
rs7216389
BECs: 1.9 3 1023;
BAL fluid: .04
BECs: 4.7 3 1023;
BAL fluid: NS
BECs: 1.1 3 1023;
BAL fluid: NS
BECs: NS; BAL fluid:
NS
BECs: NS; BAL fluid:
NS
BECs: NS; BAL fluid:
NS
BAL, Bronchoalveolar lavage; CBMC, cord blood mononuclear cell; NK, natural killer; NS, not significant; RV inf, rhinovirus infection; Treg, regulatory T.
Symbols after references designate whether gene expression studies were performed by using quantitative PCR (*), microarray (), or RNA-seq (). P values are shown as reported
in each article for the genes included in each study.
SNP rsID Asthma Risk Allele
Whole Blood (n=338) Lung Tissue (n=278)
GSDMB ORMDL3 PGAP3 GSDMB ORMDL3 GSDMA
Effect 
Size P-value
Effect
Size P-value
Effect
Size P-value
Effect
Size P-value
Effect
Size P-value
Effect
Size P-value
rs2941504 A 0.19 1.00E-07 0.15 5.60E-05 0.22 1.70E-09 n.s. n.s. 0.2 1.30E-06 n.s. n.s.
rs2517955 C 0.17 8.00E-07 0.16 1.50E-05 0.23 1.00E-09 n.s. n.s. 0.18 9.10E-06 n.s. n.s.
rs2952156 A 0.21 1.80E-09 0.17 6.60E-06 0.23 1.50E-09 n.s. n.s. 0.22 2.70E-07 n.s. n.s.
rs907092 G 0.29 6.90E-20 0.32 3.10E-21 n.s. n.s. n.s. n.s. 0.19 3.50E-06 -0.36 6.30E-06
rs9303277 C 0.34 6.70E-28 0.34 5.80E-26 0.15 1.40E-05 0.17 9.20E-07 0.27 4.60E-13 -0.36 1.90E-06
rs12936231 C 0.33 1.30E-29 0.35 5.70E-29 n.s. n.s. 0.16 9.80E-07 0.29 6.40E-15 -0.37 4.70E-07
rs8069176 G 0.29 7.70E-22 0.33 1.30E-26 n.s. n.s. n.s. n.s. 0.23 4.80E-09 -0.42 1.50E-08
rs2305480 G 0.31 8.00E-22 0.35 8.00E-26 n.s. n.s. n.s. n.s. 0.23 2.60E-08 -0.43 3.10E-08
rs11078927 C 0.31 1.00E-21 0.35 8.80E-26 n.s. n.s. n.s. n.s. 0.23 2.50E-08 -0.44 2.80E-08
rs11078928 T 0.31 1.50E-21 0.36 3.90E-27 n.s. n.s. n.s. n.s. 0.24 1.10E-08 -0.45 2.00E-08
rs2290400 T 0.31 2.10E-25 0.34 2.10E-27 0.14 6.30E-05 0.16 2.10E-06 0.29 1.20E-14 -0.38 2.50E-07
rs7216389 T 0.31 1.70E-22 0.36 9.00E-29 n.s. n.s. 0.19 1.50E-07 0.28 2.50E-12 -0.41 1.60E-07
rs4065275 G 0.34 2.20E-27 0.34 1.60E-25 n.s. n.s. 0.16 3.30E-06 0.27 2.50E-12 -0.47 4.70E-10
rs8076131 A 0.32 3.40E-23 0.37 1.10E-29 n.s. n.s. n.s. n.s. 0.24 4.50E-09 -0.5 4.40E-10
rs12603332 C 0.32 3.20E-27 0.33 1.10E-25 0.14 4.30E-05 0.17 8.70E-07 0.28 1.70E-13 -0.47 1.10E-10
rs3894194 A 0.23 1.00E-13 0.23 5.90E-12 n.s. n.s. n.s. n.s. 0.22 7.00E-09 -0.60 4.80E-17
rs3859192 T 0.19 1.70E-09 0.19 1.60E-08 n.s. n.s. n.s. n.s. n.s. n.s. -0.77 1.50E-30
FIG 6. GTEx project eQTLs for 17q genes in whole blood and lung tissue at a false discovery rate of 5%. 17q
SNPs were eQTLs for only 2 of the 6 genes in whole blood and 4 of the 6 genes in lung tissue; the remaining
genes (without significant eQTLs) are not shown. SNPs in the proximal region are shown on a blue
background, SNPs in the core region are shown on an orange background, and SNPs in the distal region are
shown on a green background (see Fig 1). The GTEx project sample composition is approximately 84%
white, 14% African American, 1% other, and 1% unknown (https://gtexportal.org/home/
tissueSummaryPage). n.s., Not significant.
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SNP rsID
Asthma 
Risk 
Allele
LD r2 with 
rs12936231 
in YRI
Asthma 
Risk Allele 
Frequency 
in YRI
eQTLs in YRI LCLs (n=56)
EVE Meta-Analysis 
of Asthma GWAS in 
African Americans
GSDMB ORMDL3
P-value P-value Meta P-value OR
rs2941504 A 0.09 0.49 0.59 1.3E-03 0.196 1.05
rs2517955 C 0.00 0.89 0.40 0.77 0.144 1.06
rs2952156 A 0.09 0.52 0.57 0.01 0.607 1.02
rs907092 G 0.02 0.97 0.10 0.69 0.022 1.14
rs9303277 C 0.73 0.56 0.01 5.48E-07 0.115 1.06
rs12936231 C 1.0 0.54 0.03 5.35E-10 0.348 1.06
rs8069176 G 0.39 0.67 0.11 2.43E-04 0.064 1.11
rs2305480 G 0.07 0.96 0.29 0.31 0.009 1.17
rs11078927 C 0.07 0.96 0.34 0.21 0.001 1.23
rs11078928 T 0.07 0.96 0.26 0.32 n.i. n.i.
rs2290400 T 0.50 0.61 0.04 1.96E-04 0.174 1.03
rs7216389 T 0.16 0.89 0.29 0.06 0.097 1.06
rs4065275 G 0.28 0.75 0.16 0.01 n.i. n.i.
rs8076131 A 0.10 0.09 0.47 0.53 0.003 1.17
rs12603332 C 0.43 0.56 0.24 2.52E-03 0.089 1.05
rs3894194 A 0.17 0.30 0.50 0.09 0.241 1.05
rs3859192 T 0.10 0.32 0.77 0.03 0.433 1.03
FIG 7. eQTLs for ORMDL3 and GSDMB in Nigerian (YRI) LCLs93 and associations with asthma in African
Americans.5 LD between each SNP and the lead eQTL (rs12936231) are shown in the third column. eQTLs
and GWAS P values of .01 or less are shown in boldface. SNPs in the proximal region are shown on a
blue background, SNPs in the core region are shown on an orange background, and SNPs in the
distal region are shown on a green background (see Fig 1). n.i., No information available (SNPs not
imputed).
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STEIN ET AL 759promoter and enhancer activity in LCLs (CEU), Berlivet et al99
provided further evidence for an enhancer of ORMDL3 located
in ZPBP2. Acevedo et al34 focused on 3 SNPs within CpG
dinucleotides: the risk allele at rs7216389 in GSDMB removes
a CpG site, and the risk alleles at rs4065275 and rs12603332
in ORMDL3 create CpG sites. These SNPs affected methylation
levels both at the position at which they are located and at
other CpG sites in the 59 untranslated region of ORMDL3.
The asthma-associated SNPs and allele-specific methylation
patterns were associated independently with expression of
ORDML3 and GSDMB in PBLs, but only methylation patterns
at, but not expression of, ORMDL3 differed between children
with and without asthma.DNA methylation and gene regulation in BECs
Nicodemus-Johnson et al20 performed genome-wide eQTL and
meQTL mapping in freshly isolated BECs from 74 asthmatic and
41 nonasthmatic adults. The most significant eQTL for ORMDL3
was rs2517955, which is located 240 bp from ORMDL3 in an
intron of PGAP3 (eQTL P 5 1.56 3 1025) and shows little LD
with genotypes at the core locus (Fig 1, D). This SNP was also
a significant eQTL for PGAP3 (P 5 2.07 3 1028) but not for
GSDMB or any other genes at the core locus. SNP rs2517955was also a meQTL for a nearby CpG, cg05616858 (meQTL
P 5 8.95 3 10213), which was itself correlated with expression
of ORMDL3 (P 5 3.87 3 1024).
A conditional analysis that accounted for genotype at the core
17q locus confirmed that the association between rs2517955 and
ORMDL3 expression is independent of SNPs at the core locus. To
elucidate the causal relationship between rs2517955 genotype,
cg05616858 methylation, and ORMDL3 gene expression, the
investigators used Mendelian randomization and showed that
methylation at this CpG site directly influences ORMDL3
expression level independent of rs2517955. This SNP was
also associated with asthma in the TAGC Consortium
(P 5 7.6 3 10229).
Interestingly, rs2517955 resides within a peak of H3K27ac
histone marks in ENCODE data (all cell types pooled), which
is suggestive of an enhancer in this region. Chromatin
capture (Hi-C) studies in LCLs demonstrated looping and
physical interaction between the putative enhancer at
rs2517955 and the promoter of ORMDL3, approximately 240
kb away,20 which is consistent with the correlated expression
levels of these 2 genes in PBLs, BECs, and ASMCs (Fig 4),
providing a potential mechanism for these observations and
supporting an independent asthma risk locus in the proximal
17q region.
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FIG 8. Allele-specific chromatin modification and gene expression at the 17q locus. A, Schematic
representation of the CTCF-binding motifs that overlap with the asthma-associated SNPs rs12936231 in
ZPBP2 and rs4065275 in ORMDL3 (modified from Schmiedel et al21). Relative expression of ORMDL3
from the C-A haplotype was inferred from 1 YRI subject who was heterozygous C-A/G-A (ORMDL3
fragments per kb million [FPKM] 5 26; see Fig 8, B). Predicted haplotype frequencies are based on allele
frequencies and LD estimates (see Fig 1). B, ORMDL3 and GSDMB gene expression in LCLs and phased
genotype data for 29 YRI subjects98 who are homozygous for 3 of the rs12936231-rs4065274 haplotypes;
no subjects were homozygous for the C-A haplotype. The y-axis shows FPKM, a measure of gene
expression after normalizing for sequence depth and gene length.
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Although our understanding of the 17q asthma locus has
deepened significantly since its discovery, research over the past
few years has revealed appreciable levels of complexity for this
locus. Importantly, several lines of evidence support the presence
of 3 independent asthma-associated loci at the extended 17q12-21
region.
At least 2 SNPs at the core locus directly regulate the
expression of ORMDL3 or GSDMB in immune cells. The
asthma-associated allele in GSDMB, rs11078928-T, is associated
with higher expression of this gene because of aberrant splicing
associated with the alternate C allele, and the rs12936231-C
allele in ZPBP2 that destroys a CTCF motif is associated with
increased expression of ORMDL3. Because of LD, 2 haplotypes
corresponding to high and low expressers of ORMDL3 and
GSDMB account for 95% of non-African haplotypes. However,
these 2 SNPs have very different allele frequencies and are inlow LD on African-derived chromosomes (Fig 1, C and D),
potentially breaking up the coregulation of these 2 genes in
African ancestry populations. Moreover, 18.5% of African-
derived chromosomes are recombinants carrying the
rs12603332-G allele, which is associated with low expression
of ORMDL3, and the rs4065275-G allele, which is associated
with high expression of ORMDL3, in subjects of non-African
ancestry (Fig 8, A). However, in African subjects this haplotype
is associated with low expression of ORMDL3 (Fig 8, B),
indicating that rs12936231 in ZPBP2 has a ‘‘dominant’’ effect
on expression of ORMDL3. Therefore it is not surprising that
rs12936231 is the most significant eQTL for ORMDL3 in whole
blood and lung tissue cells (Fig 5) and in African-derived LCLs
(Fig 6). Thus if high expression of ORMDL3 by itself was the
underlying cause of asthma, this SNP in ZPBP2 should be
associated with asthma in GWASs. Yet rs12936231 has never
been reported as a lead SNP in GWASs.
J ALLERGY CLIN IMMUNOL
VOLUME 142, NUMBER 3
STEIN ET AL 761The long-range looping and correlated expression patterns
between PGAP3 in the proximal region and ORMDL3 in the
core region and the correlated expression of their transcripts are
intriguing and raise additional questions. Are the combinations
of genotypes at the proximal and core locus SNPsmore associated
with asthma than each individually? Are the chromatin
interactions and looping between PGAP3 and ORMDL3 inhibited
by the binding of CTCF at rs12936231 as for looping within the
core locus? Do PGAP3 and ORMDL3 proteins functionally
interact to promote asthma? At the present time, little is
known about the function of PGAP3, which is a
glycosylphosphatidylinositol (GPI)–specific phospholipase that
is expressed ubiquitously and localizes primarily to the Golgi
apparatus. It is predicted to encode a 7-transmembrane protein
that removes fatty acids from GPI, which might be important for
proper association between GPI-anchored proteins and lipid
rafts.100 A role for PGAP3 in asthma has not yet been explored.
In contrast, many potential functions have been attributed to
ORMDL3, including sphingolipid metabolism,101-106 ER
stress,17,107-110 eosinophil trafficking,111 and responses to
Alternaria species,112 respiratory syncytial virus,91 polyinosinic:
polycytidylic acid,53 and IL-17 secretion (reviewed in Das
et al).18,36
Although less is known about GSDMA, a missense variant
(rs3894194) has shown independent associations for asthma and
specific lung phenotypes, and an SNP (rs3859192) in this gene
is an eQTL for GSDMA in lung tissue cells. These 2 SNPs
show very little LD with each other in all populations. As a result,
a relationship between the eQTL or between GSDMA expression
and asthma per se has not been established. Additionally, the
eQTL should be interpreted cautiously because of the very low
expression of GSDMA in lung cells.
Finally, the combined observations of consistently strong
associations between 17q SNPs with both early-onset asthma
and expression of 17q genes but conflicting evidence for
increased expression of 17q genes in immune cells or airway
cells in older children and adults with asthma is enigmatic and
might suggest that the critical window for regulating the
expression of ORMDL3, GSDMB, or other 17q genes occurs in
the first few years of life. In that case studying children at
school age or later will miss this relationship. Additionally,
specific exposures, such as viruses or other microbes, can
enhance genotype-specific differences in transcript abundance
between asthmatic and nonasthmatic children, as suggested
by a study in cord blood mononuclear cells.18 Prospective birth
cohorts will be required to examine early-life gene expression
and epigenetic patterning and the subsequent development of
asthma. Ideally, these studies would be performed in both im-
mune and airway cells during periods of wellness and during
respiratory tract infections in the first few years of life and
include ethnically diverse children and children exposed to
different environments in infancy. More comprehensive and
integrative studies of 17q genotype with gene expression and
epigenetic variation using systems biology approaches in care-
fully phenotyped children will yield further insights into the
genetic risk architecture of this important locus. Given the cur-
rent pace of research, we expect the next decade to yield an-
swers to these questions and translate findings into asthma
prevention strategies for children with the 17q high-risk
genotype.What do we know?
d The asthma locus on 17q12-21 is the most replicated and
most significant finding in GWASs of asthma.
d Variation at this locus is specifically associated with very
early-onset asthma, possibly before age 3 years, when it
manifests as wheezing illness.
d The 17q genotype’s effects on asthma risk and protection
are modified by early-life exposures.
d The extensive LD across this region in populations of
European and Asian ancestry is greatly reduced in
populations of African ancestry.
d The asthma-associated 17q SNPs are eQTLs for the
nearby genes GSDMA, ORMDL3, GSDMB, and PGAP3
in immune cells, lung cells, or both.
d The regulatory architecture of the 17q genes differs in
immune and lung cells.
d Variation at this locus is also associated with autoimmune
diseases; alleles associated with asthma risk are often
associated with protection from autoimmune disease
and vice versa.
What is still unknown?
d Is genetic variation at the extended 17q12-21 locus
associated with early-life wheezing illness and
childhood-onset asthma in African American children?
d Which 17q gene or genes (ORMDL3, GSDMB, PGAP3,
and/or GSDMA) are involved in early-life wheezing and
asthma pathogenesis?
d What are the functions of and through what mechanisms
do the 17q genes affect asthma onset and severity?
d In which cell types (blood cells, airway cells, or both) are
the expression of these genes most relevant to the 17q
asthma-associated risks or specific endotypes?
d Do the same 17q gene or genes modulate both protection
against asthma in children exposed to animals and risk
for asthma in children not exposed to animals?
d What is the natural history of asthma in later childhood
and after puberty in subjects with the high-risk 17q
genotype?
d Which genes and what mechanisms account for the
opposite associations of 17q alleles with asthma and
autoimmune diseases?REFERENCES
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METHODS
PBLs were obtained from 112 Hutterite subjects (age range, 7-76 years), a
founder population of European ancestry in a study approved by the
Institutional Review Board at the University of Chicago. Written consent
for these studies was obtained from the adult participants and parents of
children less than 18 years of age; written assent was obtained from all
children. One milliliter of whole blood was drawn into a TruCulture (Myriad
RBM, Austin, Tex) tube containing proprietary TruCulture media and
incubated upright in a dry heat block at 378C for 30 hours. Samples were
washed twice with Buffer EL (Qiagen, Hilden, Germany), and cell pellets
were resuspended in 350 mL of RLT Buffer (Qiagen) and frozen on dry ice.
RNAwas extracted from thawed cell pellets by using AllPrep DNA/RNA
Mini Kits (Qiagen). RNA-seq libraries were madewith the TruSeq Library kit
(Illumina, San Diego, Calif); quality and concentration of libraries were
assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, Calif) and quantitative PCR by using the Kapa library quantification kit
(Kapa Biosystems, Wilmington, Mass). Samples were sequenced in pools of
16 to 18 samples across 3 flow cells of an Illumina HiSeq 2500; 119 samples
with low read counts were resequenced on 2 flow cells on the same machine.
Reads were mapped to hg19, and genes were counted with STAR.E1 Samples
with more than 7million uniquelymapped reads underwent trimmedmeans of
M-value normalization and a voom transformation, which was used to correct
for differences in library sizes.E2 Confounding technical effects were assessed
in the normalized expression data by using principal components analysis
(PCA), and the sequencing pool was adjusted by using the function
RemoveBatchEffect() from the R package Limma.E3
Lung CD4 TRM cells were sorted from 20 human organ donors whose
lungs were not used for transplantation and provided by the Gift of Hope
Organ and Tissue Donor Network. Fifty million lung leukocytes were
thawed and centrifuged over Histopaque 1077 (Sigma, St Louis,Mo) gradient,
as previously described.E4 Cells were then stained with antibodies for
fluorescence-activated cell sorting of CD4 TRMs with the CD451CD2062
CD142CD31CD11b2CD41CD82CDRO1CD11a1 phenotype. RNA was
extracted from cells by using AllPrep DNA/RNA Mini Kits (Qiagen).
RNA-seq libraries were made by using the SMART seq v4 Ultra Low Input
RNA kit (Takara, Shiga, Japan); quality and concentration of libraries were
assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies), and
quantitative PCR was done with the Kapa library quantification kit (Kapa
Biosystems). Samples were sequenced in pools with 84 samples (including
other samples) across 3 flow cells of an Illumina HiSeq 2500; 4 samples
with low read counts were resequenced on 2 flow cells on the same machine.
Reads were mapped to hg19, and genes were counted by using TopHat2.E5
Samples with greater than 8 million uniquely mapped reads underwent
trimmed means of M-value normalization and a voom transformation, which
was used to correct for differences in library sizes.E2 Confounding technical
effects were assessed in the normalized expression data using PCA, and no
confounding effects were seen with extraction batch, library batch, pool, or
lane. Effects for age, sex, race, and date of cell sorting were removed by using
linear regression in the R package Limma.E3
Primary ASMCs were isolated from 75 human donor lungs that were not
suitable for transplantation and provided by the Gift of Hope Organ and
Tissue Donor Network. Cells were isolated from trachea and main bronchi
by using established techniques.E6 Cells were cultured in 75-cm2 flasks
in DMEM/F-12 media (Invitrogen, Carlsbad, Calif) supplemented with
10% FBS, 5% nonessential amino acids (Invitrogen), and 5% antibiotic/
antimycotic (Invitrogen). RNA was isolated by using the QIAgen AllPrep
Kit (Qiagen) and hybridized to Illumina Human HT-12 v4 arrays at the
University of Chicago Genomics Facility. Probe-level raw intensity values
across arrays were normalized by using quantile normalization, and
background-corrected normalized expression values were obtained for
each probe by using the R package lumi.E7 A total of 67 samples had
adequate array intensities and were further processed. Probes that were
indistinguishable from background intensity (P < .01), contained more
than 1 HapMap SNP, or mapped to multiple locations in the genomeE8
were removed. Median probe intensity was used to represent the
transcriptional abundance of each gene. Extraction batch, chip, RNA
concentration, cell line age, and plate were identified as potential
confounders by using PCAE9 of gene expression data. The effects of culture
and extraction batch, chip, and plate were removed by using ComBat,E10
whereas the effects of the quantitative variables (RNA concentration and
cell line age) were removed by using linear regression.
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FIG E1. LD (r2) among the 17 SNPs described in Fig 2 in Nigerians (YRI) by using the 1000 Genomes
reference panel.
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TABLE E1. Asthma-associated allele frequencies in Nigerians
(YRI) from the 1000 Genomes reference panel
SNP Asthma-associated allele Frequency No.
rs2941504 A 0.5 207
rs2517955 C 0.8575 207
rs2952156 A 0.4469 207
rs907092 G 0.8986 207
rs9303277 C 0.372 207
rs12936231 C 0.4227 207
rs8069176 G 0.6377 207
rs2305480 G 0.9058 207
rs11078927 C 0.91063 207
rs11078928 T 0.91304 207
rs2290400 T 0.5266 207
rs7216389 T 0.814 207
rs4065275 G 0.6667 207
rs8076131 A 0.8599 207
rs12603332 C 0.3623 207
rs3894194 A 0.2681 207
rs3859192 T 0.3213 207
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